Uroguanylin Action in the Brain Reduces Weight Gain in Obese Mice via Different Efferent Autonomic Pathways

The gut-brain axis is of great importance in the control of energy homeostasis. The identification of uroguanylin (UGN), a peptide released in the intestines that is regulated by nutritional status and anorectic actions, as the endogenous ligand for the guanylyl cyclase 2C receptor has revealed a new system in the regulation of energy balance. We show that chronic central infusion of UGN reduces weight gain and adiposity in diet-induced obese mice. These effects were independent of food intake and involved specific efferent autonomic pathways. On one hand, brain UGN induces brown adipose tissue thermogenesis, as well as browning and lipid mobilization in white adipose tissue through stimulation of the sympathetic nervous system. On the other hand, brain UGN augments fecal output through the vagus nerve. These findings are of relevance as they suggest that the beneficial metabolic actions of UGN through the sympathetic nervous system do not involve nondesirable gastrointestinal adverse effects, such as diarrhea. The present work provides mechanistic insights into how UGN influences energy homeostasis and suggests that UGN action in the brain represents a feasible pharmacological target in the treatment of obesity.

[1]  F. Casanueva,et al.  Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner , 2016, European Journal of Nutrition.

[2]  H. Münzberg,et al.  Leptin and Insulin Act on POMC Neurons to Promote the Browning of White Fat , 2015, Cell.

[3]  D. Morgan,et al.  Leptin Receptor Signaling in the Hypothalamus Regulates Hepatic Autonomic Nerve Activity via Phosphatidylinositol 3-Kinase and AMP-Activated Protein Kinase , 2015, The Journal of Neuroscience.

[4]  Jing Wu,et al.  O-GlcNAc Transferase Enables AgRP Neurons to Suppress Browning of White Fat , 2014, Cell.

[5]  B. Cannon,et al.  The browning of white adipose tissue: some burning issues. , 2014, Cell metabolism.

[6]  K. Rahmouni,et al.  The brain and brown fat , 2014, Annals of medicine.

[7]  F. Villarroya,et al.  GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK , 2014, Diabetes.

[8]  S. Woods,et al.  Effect of Guanylate Cyclase-C Activity on Energy and Glucose Homeostasis , 2014, Diabetes.

[9]  S. Morrison,et al.  Central neural regulation of brown adipose tissue thermogenesis and energy expenditure. , 2014, Cell metabolism.

[10]  T. Lam,et al.  Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes , 2013, Diabetes.

[11]  D. Morgan,et al.  Amylin acts in the central nervous system to increase sympathetic nerve activity. , 2013, Endocrinology.

[12]  M. J. Vazquez,et al.  Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. , 2013, Gastroenterology.

[13]  D. Marks,et al.  Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques , 2013, Diabetes.

[14]  C. Diéguez,et al.  Female Nur77-Deficient Mice Show Increased Susceptibility to Diet-Induced Obesity , 2013, PloS one.

[15]  S. Visweswariah,et al.  The multiple and enigmatic roles of guanylyl cyclase C in intestinal homeostasis , 2012, FEBS letters.

[16]  S. Levy,et al.  Familial diarrhea syndrome caused by an activating GUCY2C mutation. , 2012, The New England journal of medicine.

[17]  S. Waldman,et al.  A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. , 2011, The Journal of clinical investigation.

[18]  R. Seeley,et al.  Uroguanylin: how the gut got another satiety hormone. , 2011, The Journal of clinical investigation.

[19]  M. Currie,et al.  Two randomized trials of linaclotide for chronic constipation. , 2011, The New England journal of medicine.

[20]  L. Seoane,et al.  The vagus nerve as a regulator of growth hormone secretion , 2011, Regulatory Peptides.

[21]  Ricardo Lage,et al.  Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance , 2010, Nature Medicine.

[22]  R. Nogueiras,et al.  Regulation of lipid metabolism by energy availability: a role for the central nervous system , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[23]  S. Woods,et al.  Direct Control of Peripheral Lipid Deposition by CNS GLP-1 Receptor Signaling Is Mediated by the Sympathetic Nervous System and Blunted in Diet-Induced Obesity , 2009, The Journal of Neuroscience.

[24]  L. Avery,et al.  Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety. , 2008, Cell metabolism.

[25]  S. O’Rahilly,et al.  The central melanocortin system directly controls peripheral lipid metabolism. , 2007, The Journal of clinical investigation.

[26]  K. Kaun,et al.  Natural variation in food acquisition mediated via a Drosophila cGMP-dependent protein kinase , 2007, Journal of Experimental Biology.

[27]  C. K. Song,et al.  Brain-adipose tissue neural crosstalk , 2007, Physiology & Behavior.

[28]  D. Cummings,et al.  Gastrointestinal regulation of food intake. , 2007, The Journal of clinical investigation.

[29]  P. Pfluger,et al.  Ghrelin action in the brain controls adipocyte metabolism. , 2006, The Journal of clinical investigation.

[30]  G. Sanger,et al.  Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. , 2002, Current opinion in pharmacology.

[31]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[32]  D. Garbers,et al.  Guanylyl cyclase is a heat-stable enterotoxin receptor , 1990, Cell.

[33]  G. Frühbeck Gastrointestinal hormones: Uroguanylin—a new gut-derived weapon against obesity? , 2012, Nature Reviews Endocrinology.

[34]  M. Rewers,et al.  Autoimmunity: Celiac disease in T1DM—the need to look long term , 2012, Nature Reviews Endocrinology.